All In Biotech

Drug Trial Radar · NCT01390961

Comparison of Tolerability Between Two Allergy Drops

Last checked: Nov 19, 2026Latest source record: Jul 11, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

48

Planned (sponsor's estimate)

Start

Aug 2011

Primary completion

Dec 2011

Study completion Jan 2012

Sponsor

Lead sponsor
Hom, Milton M., OD, FAAOIndividual
Sponsor type
Individual
Collaborators
Allergan
First posted
Jul 11, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
Single (investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 months
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Comfort is compared between two allergy drops

Conditions

  • Allergic Conjunctivitis

Interventions

  • alacaftadine and naphazoline HCl & pheniramine maleateDrug

    once a day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. TolerabilityTime frame: 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Milton M. Hom, OD, FAAO.

    Azusa, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.